July 21, 2022

The Summer 2022 edition of Magnify, now online, features a look at the challenges of autoimmune neurologic testing, our experts in this area, and recent awards, and catches up with a former fellow.

July 20, 2022

ARUP medical directors and scientists will share their research and expertise in areas like lab stewardship, biochemical genetics, and neonatal drug testing at AACC’s 2022 annual meeting in Chicago.

July 18, 2022

Scientist Michael T. Pyne shares ARUP’s challenges and process of developing a next generation sequencing (NGS) test for HIV-1 antiretroviral drug resistance.

July 6, 2022

ARUP Consult, a free source of expert guidance in laboratory testing, has released new and updated resources on testing for immunobullous diseases, diabetes mellitus, and prostate cancer.

June 23, 2022

ARUP offers several antibody panels to test for immunobullous diseases, which are difficult to diagnose. The Immunobullous Disease Testing Comparison tool allows users to quickly compare test options.

June 15, 2022

ARUP experts say that the VALID Act, which would require FDA approval of all lab-developed tests, would add administrative and financial burdens to an already safe and effective validation process.

June 13, 2022

ARUP Laboratories invites medical professionals to participate in a free webinar that will feature creative solutions to address the current laboratory and hospital staffing crisis.

June 10, 2022

ARUP’s Dan Anderson will participate in a SmartBrief webinar on June 16 to share lessons learned from COVID-19 in an effort to help laboratories prepare for future pandemics.